The smart inhalers market refers to the segment of the medical device industry that deals with the production and sales of inhalers that have been integrated with digital technology. Smart inhalers are designed to improve patient adherence to treatment and provide real-time data to healthcare providers.
Smart inhalers are typically equipped with sensors that track usage, allowing patients to monitor their medication adherence and providing healthcare providers with valuable information on medication usage and treatment efficacy. Some smart inhalers also come equipped with features such as reminders and alerts, automatic dose counting, and the ability to connect to a mobile app for tracking and monitoring.
Worldwide revenue from the smart inhalers market stands at US$ 80.5 Mn in 2022, with the global market estimated to expand at a CAGR of 10.2% to reach US$ 235.7 Mn by the end of 2033.
Request For Free Sample Report of “Smart Inhalers Market”@ https://www.persistencemarketresearch.com/samples/26881
One of the key drivers of the smart inhalers market is the increasing prevalence of respiratory conditions such as asthma and COPD. With more people suffering from these conditions, there is a growing need for innovative solutions to help patients manage their medication regimen and improve adherence.
Another important factor driving the growth of the smart inhalers market is the increasing use of technology in healthcare. Smart inhalers use sensors, software, and connectivity to provide real-time feedback on medication usage, which can help patients and healthcare providers monitor medication usage and adjust treatment plans as needed.
Companies
- OPKO Health, Inc
- AstraZeneca plc
- GlaxoSmithKline Plc.
- Propeller Health
- Aptar Pharma
- Adherium Limited
- Novartis AG
- Boehringer Ingelheim
- Teva Pharmaceutical Industries Ltd
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/26881
The market is segmented by product, applications and end-users. The product segment includes sensor-enabled inhalers, digital inhalers, and connected inhalers. Applications are segmented into asthma, COPD and others. End-users are segmented into hospitals, homecare and others
The smart inhalers market is also characterized by the presence of several major players, such as GlaxoSmithKline, Propeller Health, AstraZeneca, and Teva Pharmaceuticals. These companies offer a wide range of smart inhalers products and services.
In conclusion, the smart inhalers market is expected to continue to grow in the coming years, driven by increasing prevalence of respiratory conditions such as asthma and COPD and the increasing use of technology in healthcare. Smart inhalers can help patients manage their medication regimen and improve adherence, providing real-time feedback on medication usage which can help patients and healthcare providers monitor medication usage and adjust treatment plans as needed.
Competitive Landscape
To enhance their market position, players in the market are putting more and more emphasis on partnerships, acquisitions, mergers, and expansion.
For instance,
- Adherium Limited formed a partnership with Trudell Medical Limited in August 2022 to provide remote monitoring and respiratory eHealth solutions to patients in the United States. With the aim of lowering readmissions and improving patient outcomes, both businesses will examine COPD patients after they leave the hospital utilising the Trudell U.S. unit Monaghan Health center and its subsidiary Aetonix’s TouchAway platform in conjunction with Adherium’s Hailie sensors.
- The U.S. FDA 510(k) approved the Hailie Sensor, which contains physiological parameters for monitoring the use of asthma and COPD medicines for sale in the U.S. region, in September 2021, according to an announcement made by Adherium Limited, a major player in the respiratory eHealth remote monitoring market.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/26881
Key Segments of the Smart Inhalers Industry Research
By Product:
- Dry Powder Inhaler (DPI)- based Smart Inhalers
- Metered Dose Inhaler (MDI)- based Smart Inhalers
By Disease Indication:
- Asthma
- COPD
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
For More Premium Insights, Check out the Link:
Hospital Acquired Infection Control Market
Endoscopic Spinal Surgery Market
Animal Drug Compounding Market
Rheumatoid Arthritis Treatment Market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
